23rd May 2014 10:38
Cathay International Holdings Limited
("Cathay" or the "Company")
Results of Annual General Meeting
Hong Kong, 23 May 2014 - Cathay International Holdings Ltd. (LSE: CTI.L), an investment holding company and a leading investor and operator in the growing healthcare sector in the People's Republic of China ("PRC"), today announces that at the Annual General Meeting held earlier today, all resolutions were duly passed. For further details on poll voting results, please visit the Company's website at www.cathay-intl.com.hk.
Copies of all special resolutions have been submitted to the National Storage Mechanism and will shortly be available at www.hemscott.com/nsm.do.
-ENDS-
For further enquiries, please contact:
Cathay International Holdings Limited Eric Siu (Finance Director) Patrick Sung (Director and Controller) |
Tel: +852 2828 9289 |
Consilium Strategic Communications Mary-Jane Elliott / Amber Bielecka / Lindsey Neville |
Tel: +44 (0) 203 709 5708 |
About Cathay
Cathay International Holdings Limited (LSE: CTI.L), focused on the People's Republic of China ("PRC"), is an investment holding company and a leading investor and operator in the growing healthcare sector in the People's Republic of China ("PRC"). The Group employs more than 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen.
Cathay aims to identify business opportunities with emphasis on high growth healthcare markets and build them into market sector leaders, with a clear exit strategy. Cathay has demonstrated a strong track record of identifying high-growth potential investment opportunities in this area including: Lansen Group, China's leading specialty pharmaceutical company focused on rheumatology and dermatology; Haizi Group, a company engaged in the manufacture, marketing and sale of inositol and DCP; and the Yangling group, a company engaged in the extract and trading of key active ingredients for healthcare products, including inositol. To complement its healthcare portfolio, Cathay has a research and product development business focused on bringing new products to the growing Chinese market.
Cathay also has a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk.
Related Shares:
CTI.L